CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases. Its primary product, DefenCath (taurolidine and heparin), is the first FDA-approved antimicrobial catheter lock solution for reducing catheter-related bloodstream infections in hemodialysis patients. Following its August 2025 acquisition of Melinta Therapeutics, the company expanded its portfolio to include six hospital-focused anti-infective products and one cardiovascular product.
Q2 FY2026 — expected 2026-09-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001213900-26-023889 | EDGAR | 66K words |
| 2025-03-25 | 2024-12-31 | 0001013762-25-001852 | EDGAR | 50K words |
| 2024-03-12 | 2023-12-31 | 0001213900-24-021585 | EDGAR | 65K words |
| 2023-03-30 | 2022-12-31 | 0001213900-23-024310 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001213900-22-015852 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001213900-21-018684 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001213900-20-006521 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001654954-19-002741 | EDGAR | — |
| 2018-03-19 | 2017-12-31 | 0001654954-18-002777 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001654954-17-002094 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001410098-26-000056 | EDGAR | 21K words |
| 2025-11-12 | 2025-09-30 | 0001213900-25-108777 | EDGAR | 42K words |
| 2025-08-07 | 2025-06-30 | 0001213900-25-072843 | EDGAR | 33K words |
| 2025-05-06 | 2025-03-31 | 0001213900-25-039908 | EDGAR | 20K words |
| 2024-10-30 | 2024-09-30 | 0001213900-24-091961 | EDGAR | 23K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068600 | EDGAR | 23K words |
| 2024-05-09 | 2024-03-31 | 0001213900-24-041031 | EDGAR | 18K words |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086981 | EDGAR | 22K words |
| 2023-08-08 | 2023-06-30 | 0001213900-23-064244 | EDGAR | 22K words |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039793 | EDGAR | 19K words |
| 2022-11-10 | 2022-09-30 | 0001213900-22-070834 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001213900-22-046617 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-13 | 0001410098-26-000054 | EDGAR | 4K words |
| 2026-08-07 | 0001410098-26-000044 | EDGAR | 16K words |
| 2026-03-06 | 0001213900-26-024777 | EDGAR | 4K words |
| 2026-03-05 | 0001213900-26-023881 | EDGAR | 4K words |
| 2026-01-08 | 0001213900-26-002350 | EDGAR | 2K words |
| 2025-11-12 | 0001213900-25-108716 | EDGAR | 3K words |
| 2025-10-20 | 0001213900-25-100156 | EDGAR | 1K words |
| 2025-09-02 | 0001213900-25-082956 | EDGAR | 2K words |
| 2025-08-12 | 0001213900-25-075010 | EDGAR | 68K words |
| 2025-08-07 | 0001213900-25-072814 | EDGAR | 11K words |
386 total filings indexed. 354 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001410098 |
| Ticker | CRMD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cormedix.com |
| Listed | 2010-05-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CRMD (~200 tokens, structured JSON with cryptographic provenance)